Judges Scientific Regulatory News (JDG)

Judges Scientific plc (the "Company")

9 December 2015

Director/PDMR Shareholding

Judges Scientific has been advised that purchases of Ordinary Shares of 5p each in the Company ("Ordinary Shares") were made on 7 December 2015 by the Trustees of the Share Incentive Plan on behalf of one Director of the Company, as follows:

A total of ten Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company. His resulting interest in the Company is 916,672 Ordinary Shares representing 15.03 per cent of the issued Ordinary share capital. In addition, he holds options over 9,275 Ordinary Shares under the Company's Share Option Plans.

The purchases by the Trustees were made at a price of 1487.5p per Ordinary Share. Purchases of a further 581 Ordinary Shares were made on the same date and at the same price on behalf of 76 other members of staff under the Plan.

For further information please contact:

Judges Scientific plc

David Cicurel, CEO

Tel: 0203 829 6970

Shore Capital (Nominated Adviser & Broker)

Pascal Keane

Edward Mansfield

Tel: 020 7408 4090

Cardew Group (Financial Public Relations)

Melvyn Marckus

Tel: 020 7930 0777 or 07775 896 491

Website:

Judges Scientific: www.judges.uk.com